Aclaris therapeutics to participate in the hc wainwright “hcw@home” series

Wayne, pa., may 09, 2025 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that aclaris' chief executive officer neal walker and other members of the aclaris senior leadership team will participate in a fireside chat during the virtual hc wainwright “hcw@home” series. the virtual fireside chat will take place on friday may 16, 2025, at 1:00 pm edt.
ACRS Ratings Summary
ACRS Quant Ranking